ANDREW SMITH: Open Payments
NPI 1730926668 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 111 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $641 · 2025 $1,208
Food & beverage: $1,208
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $298 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 22 | $282 |
| E.R. Squibb & Sons, L.L.C. | 45 | $203 |
| Amgen Inc. | 4 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Merck Sharp & Dohme LLC | 4 | $68 |
| CVRx, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: LifeVest, LEQVIO, ELIQUIS, REPATHA, JARDIANCE, CAMZYOS, Kerendia, VERQUVO.
Industry payments across KS — which companies pay providers there.
